Interferon alpha for treatment of chronic myeloid leukemia

Keyphrases

• Interferon-α (IFN-α) 100%
• Chronic Myeloid Leukemia 100%
• Imatinib 50%
• Tyrosine Kinase Inhibitor 20%
• Treatment Outcome 10%
• Medical Treatment 10%
• Treatment Duration 10%
• High Dose 10%
• Clinical Trials 10%
• Combination Treatment 10%
• Pegylated Interferon 10%
• Mass Reduction 10%
• Treatment Adherence 10%
• Improved Outcomes 10%
• Survival Benefit 10%
• Maximum Tolerated Dose 10%
• Immunology 10%
• Stem Cells 10%
• Conventional Chemotherapy 10%
• Tumor Mass 10%
• Treatment Protocol 10%
• Ara-C 10%
• Antileukemic Activity 10%
• Quiescent Stem Cells 10%
• Complete Cytogenetic Remission 10%
• Leukemia Therapy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Myeloid Leukemia 100%
• Alpha Interferon 100%
• Imatinib 50%
• Protein Tyrosine Kinase Inhibitor 20%
• Neoplasm 10%
• Combination Therapy 10%
• Clinical Trial 10%
• Remission 10%
• Chemotherapy 10%
• Maximum Tolerated Dose 10%
• Peginterferon Alpha 10%
• Cytarabine 10%